Guggenheim Capital’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-22,216
| Closed | -$1.05M | – | 1745 |
|
|
2025
Q3 | $1.05M | Buy |
22,216
+1,069
| +5% | +$51.8K | 0.01% | 903 |
|
|
2025
Q2 | $1.13M | Buy |
21,147
+15,204
| +256% | +$691K | 0.01% | 843 |
|
|
2025
Q1 | $241K | Buy |
+5,943
| New | +$252K | ﹤0.01% | 1482 |
|
|
2024
Q4 | – | Sell |
-25,198
| Closed | -$723K | – | 1690 |
|
|
2024
Q3 | $723K | Sell |
25,198
-6,705
| -21% | -$175K | 0.01% | 1248 |
|
|
2024
Q2 | $748K | Buy |
31,903
+6,866
| +27% | +$147K | 0.01% | 1252 |
|
|
2024
Q1 | $632K | Sell |
25,037
-6,185
| -20% | -$149K | ﹤0.01% | 1371 |
|
|
2023
Q4 | $729K | Buy |
+31,222
| New | +$616K | 0.01% | 1295 |
|
